HealthcareServices

Oral Solid Dosage Contract Manufacturing Market Size Forecast: Revenue and CAGR by 2029

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Oral Solid Dosage Contract Manufacturing Industry In 2025?

The oral solid dosage contract manufacturing market has experienced robust expansion recently. This market is projected to expand from $39.39 billion in 2024 to $42.39 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.6%. Factors contributing to its historical growth include the increasing worldwide population, the widespread occurrence of chronic illnesses, and an enhanced emphasis on research and development.

The oral solid dosage contract manufacturing market is poised for significant expansion in the coming years. Its size is projected to reach $55.81 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.1%. This forecasted growth is primarily driven by an uptick in outsourcing by pharmaceutical companies, ongoing advancements in drug delivery technology, and a rise in drug development activities. Additionally, prominent trends anticipated during this period include continued innovation in drug delivery technology, the integration of 3D printing, and progress in controlled-release technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Which Factors And Drivers Are Influencing The Oral Solid Dosage Contract Manufacturing Market In 2025?

The escalating need for generic pharmaceuticals is projected to stimulate the growth of the oral solid dosage contract manufacturing market. Generic drugs are medicines that possess bioequivalence to brand-name counterparts regarding dosage, strength, safety, performance, quality, and intended use. The increasing consumption of generic drugs arises from factors such as patent expirations, strategies for cost reduction, favorable regulatory frameworks, and broader access to healthcare. Oral solid dosage contract manufacturing critically supports the development and distribution of generic drugs by capitalizing on the expertise of contract manufacturers to boost their operational efficiency, curtail expenditures, ensure superior production quality, and accelerate product launch effectively. For example, in 2022, as reported by the Food and Drug Administration, a US-based federal agency, approximately 91% of all prescriptions in the USA were filled with generic drugs, with more than 32,000 generic drugs approved by the FDA. Thus, the strong demand for generic drugs is a key driver for the expansion of the oral solid dosage contract manufacturing market.

What Are The Key Segments In The Oral Solid Dosage Contract Manufacturing Market?

The oral solid dosage contract manufacturingmarket covered in this report is segmented –

1) By Product Type: Tablets; Capsules; Powders; Granules; Other Product Types

2) By Service: Drug Product Development; Fill Finish Product Manufacturing; API Manufacturing; Packaging And Labelling; Other Applications

3) By Therapeutic Area: Oncology; Cardiovascular Diseases; Metabolic Disorders; Neurological Disorders; infectious Diseases; Gastrointestinal Diseases; Other Therapeutic Areas

4) By End User: Large Size Companies; Medium And Small Size Companies

Subsegments:

1) By Tablets: Compressed Tablets; Effervescent Tablets; Chewable Tablets; Coated Tablets (Enteric, Film Coated); Sustained Or Controlled Release Tablets

2) By Capsules: Hard Gelatin Capsules; Soft Gel Capsules; Vegetarian Capsules; Liquid-Filled Capsules; Delayed Release Capsules

3) By Powders: Powders For Oral Suspension; Powders For Direct Compression; Powders For Mixing Or Blending; Instant Dissolving Powders

4) By Granules: Granules For Direct Compression; Granules For Tabletting; Effervescent Granules; Delayed Or Controlled Release Granules

5) By Other Product Types: Lozenges; Oral Strips; Oral Thin Films; Effervescent Tablets Or Granules

How Are Emerging Market Trends Shaping The Oral Solid Dosage Contract Manufacturing Industry Landscape?

Leading firms within the oral solid dosage contract manufacturing market are concentrating on creating novel solutions, like continuous manufacturing lines, to maintain their competitive standing. Such a line is defined as a production setup or system employing ongoing manufacturing methods to create medicines or various goods. An example of this is when, in January 2023, WuXi STA, a pharmaceutical enterprise from China, unveiled its inaugural continuous manufacturing line specifically for oral solid pharmaceutical items. This advanced facility represents a major leap forward in drug production, applying continuous manufacturing concepts to improve the effectiveness, standards, and adaptability of drug manufacturing operations. This improved responsiveness optimizes production schedules and minimizes idle periods, consequently speeding up the provision of essential medicines to individuals.

Who Are The Prominent Global Companies Shaping The Oral Solid Dosage Contract Manufacturing Market?

Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Which Regional Markets Are Contributing Most To The Oral Solid Dosage Contract Manufacturing Industry Expansion?

Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2024. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Oral Solid Dosage Contract Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp

Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2025, By The Business Research Company

Electronic Contract Manufacturing And Design Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electronic-contract-manufacturing-and-design-services-global-market-report

Food Contract Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/food-contract-manufacturing-global-market-report

Medical Device Contract Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-device-contract-manufacturing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795